We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · September 22, 2022

Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Patients With Fumarate Hydratase–Deficient RCC

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Genomic Characteristics and Single-cell Profiles after Immunotherapy in Fumarate Hydratase-deficient Renal Cell Carcinoma
Clin. Cancer Res 2022 Sep 08;[EPub Ahead of Print], P Dong, X Zhang, Y Peng, Y Zhang, R Liu, Y Li, QW Pan, W Wei, SJ Guo, Z Zhang, H Han, F Zhou, Y Liu, L He

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading